Mucha-Habermann's disease in children: treatment with erythromycin.
Safe therapeutic measures for Mucha-Habermann's disease in children are lacking. Three patients with the disease were treated with erythromycin for systemic effect. Although the series is small and uncontrolled, this approach seemed effective. An anti-inflammatory mechanism related to inhibition of chemotaxis is speculated.
D002648:Child; D002675:Child, Preschool; D004917:Erythromycin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D010915:Pityriasis / Q000188:drug therapy*
D004917:Erythromycin